2009 - Page 35 of 170 - Shapiro, Washburn & Sharp

Neurontin’s Effectiveness Apparently Overstated by Pfizer

“There is good evidence of selective outcome reporting in published reports of randomized trials.” So begins the abstract of a special report in the Nov. 12 New England Journal of Medicine. In the report, clinical trial and health policy experts examine original company documents and journal articles related to non-U.S. Food and Drug Administration-approved uses…

read more